Article
Lentiviral vectors can be used for full-length dystrophin gene therapy
2017-03-17
Abstract excerpt
Abstract Duchenne Muscular Dystrophy (DMD) is caused by a lack of dystrophin expression in patient muscle fibres. Current DMD gene therapy strategies rely on the expression of internally deleted forms of dystrophin, missing important functional domains. Viral gene transfer of full-length dystrophin could restore wild-type functionality, although this approach is restricted by the limited capacity of recombinant vi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8febf444-a91f-5010-ac5c-5d9ee9873eba
- DOI
- 10.1038/srep44775
